Integrative Molecular Characterization of Malignant Pleural Mesothelioma
Open accessPublished version of a preprint
The DOI matches its Crossref record; 61 of the 62 references it cites were found in a registry or an index.
Abstract
Abstract Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest cavity. To expand our understanding of MPM, we conducted a comprehensive integrated genomic study, including the most detailed analysis of BAP1 alterations to date. We identified histology-independent molecular prognostic subsets, and defined a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity. We also report strong expression of the immune-checkpoint gene VISTA in epithelioid MPM, strikingly higher than in other solid cancers, with implications for the immune response to MPM and for its immunotherapy. Our findings highlight new avenues for further investigation of MPM biology and novel therapeutic options. Significance: Through a comprehensive integrated genomic study of 74 MPMs, we provide a deeper understanding of histology-independent determinants of aggressive behavior, define a novel genomic subtype with TP53 and SETDB1 mutations and extensive loss of heterozygosity, and discovered strong expression of the immune-checkpoint gene VISTA in epithelioid MPM. See related commentary by Aggarwal and Albelda, p. 1508. This article is highlighted in the In This Issue feature, p. 1494
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Furthermore, a study that explored 74 mesothelioma tumors using a genomic analysis identified TGF-β1 mRNA expression as being correlated with the worst patient prognoses [40].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer
Bindea, G., Mlecnik, B., Tosolini, M., Kirilovsky, A., Waldner, M., Obenauf, A. C., Angell, H., Fredriksen, T., Lafontaine, L., Berger, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.10.003 · Cited by 4,422
Absolute quantification of somatic DNA alterations in human cancer
Carter, S. L., Cibulskis, K., Helman, E., McKenna, A., Shen, H., Zack, T., Laird, P. W., Onofrio, R. C., Winckler, W., Weir, B. A., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2203 · Cited by 2,053
Self-citationThe Life History of 21 Breast Cancers
Nik-Zainal, S., Van Loo, P., Wedge, D. C., Alexandrov, L. B., Greenman, C. D., Lau, K. W., Raine, K., Jones, D., Marshall, J., Ramakrishna, M., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.023 · Cited by 1,443 · cited 1×
“Since MPM with evidence of GNH have typically undergone a genome-doubling event, we were able to assess the timing of this relative to point mutations (30,31).”
BackgroundSelf-citationSomatic mutation in cancer and normal cells
Martincorena, I., & Campbell, P. J. (2015) · Science · doi:10.1126/science.aab4082 · Cited by 1,396 · cited 1×
“This places MPM at the low end of somatic mutation burden among cancers (8).”
BackgroundSelf-citationShen, R., & Seshan, V. E. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw520 · Cited by 1,258
Self-citationBroz, M. L., Binnewies, M., Boldajipour, B., Nelson, A. E., Pollack, J. L., Erle, D. J., Barczak, A., Rosenblum, M. D., Daud, A., Barber, D. L., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.09.007 · Cited by 1,207
Clock-like mutational processes in human somatic cells
Alexandrov, L. B., Jones, P. H., Wedge, D. C., Sale, J. E., Campbell, P. J., Nik-Zainal, S., & Stratton, M. R. (2015) · Nature Genetics · doi:10.1038/ng.3441 · Cited by 1,058
Self-citationBueno, R., Stawiski, E. W., Goldstein, L. D., Durinck, S., De Rienzo, A., Modrusan, Z., Gnad, F., Nguyen, T. T., Jaiswal, B. S., Chirieac, L. R., et al. (2016) · Nature Genetics · doi:10.1038/ng.3520 · Cited by 919
Self-citationShen, R., Olshen, A. B., & Ladanyi, M. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp543 · Cited by 849 · cited 1×
“To find out whether multi-platform molecular profiling might provide additional resolution to define prognostic subsets of MPM, we performed integrative clustering across multiple assay platforms using two algorithms: iCluster (32) and PARADIGM (33).”
MethodSelf-citationVaske, C. J., Benz, S. C., Sanborn, J. Z., Earl, D., Szeto, C., Zhu, J., Haussler, D., & Stuart, J. M. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq182 · Cited by 786
Self-citation
Cited by
Items 501–600 of 675
van Genugten, J., Faulkner, D., Hahne, J. C., Disselhorst, M., Wessels, L. F. A., Fennell, D. A., & Baas, P. (2025) · medRxiv · doi:10.1101/2025.05.12.25326806 · Cited by 2
Refining classification of malignant pleural mesothelioma reveals its Achilles’ heel
Pateras, I. S. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.035 · Cited by 1
Tuncel, T., Ak, G., Güneş, H. V., & Metintaş, M. (2023) · Journal of Environmental Pathology Toxicology and Oncology · doi:10.1615/jenvironpatholtoxicoloncol.2023046200 · Cited by 1
PBK Expression Promotes the Aggressive Phenotypes of Mesothelioma
Hori, K., Tanaka, I., Sato, T., Sato, M., Kodama, Y., Itoigawa, H., Abe, Y., Kato, T., Taguchi, A., Sato, M., et al. (2025) · Cancer Science · doi:10.1111/cas.70124 · Cited by 1
Self-citationAdvances in diagnosis and management of pleural mesothelioma: the Danish clinical guidelines
Panou, V., Sørensen, J. B., Ravn, J. B., & Santoni‐Rugiu, E. (2025) · European Clinical Respiratory Journal · doi:10.1080/20018525.2025.2580795 · Cited by 1
FUJITA, N., Fujita, K., Osumi, H., & Takefuji, Y. (2026) · Cancers · doi:10.3390/cancers18020221 · Cited by 1
Blanquart, C., & Scherpereel, A. (2026) · Thorax · doi:10.1136/thorax-2025-223284 · Cited by 1
High KAP1 expression promotes pleural mesothelioma cell proliferation and metastasis
Mei, W., (2007934), Y. W., Yang, S., Fu, Q., Xiong, W., & Zhang, Y. (2026) · The International Journal of Biological Markers · doi:10.1177/03936155261421213 · Cited by 1
Herman, E. J., Allione, A., Viberti, C., Manfredi, M., Russo, A., Hafeez, K. S., Kaiser, N., Johnen, G., Brüning, T., Mirabelli, D., et al. (2026) · Clinical and Experimental Medicine · doi:10.1007/s10238-026-02058-x · Cited by 1
Ollila, H., Tidjani, A., Sauter, J. L., Yang, S., Simone, C. B., Offin, M. D., & Adusumilli, P. S. (2026) · JCO Precision Oncology · doi:10.1200/po-25-01171 · Cited by 1
Taniguchi, H., Akagi, K., Fukuda, T., Honda, T., Kurohama, H., Ueki, N., Matsuoka, Y., Udo, E., Yahata, S., Miura, S., et al. (2026) · Translational Oncology · doi:10.1016/j.tranon.2026.102731 · Cited by 1
From biology to therapy: current standards and emerging strategies in pleural mesothelioma
van Genugten, J. H. L. T., de Gooijer, C. J., & Baas, P. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1778121 · Cited by 1
Emerging Strategies in the Diagnosis and Treatment of Pleural Mesothelioma: An Overview
Pagliaro, R., Leonardi, B., Schiattarella, A., Bergameo, G., Picone, C., D'Errico, A. G., Scialò, F., Perrotta, F., Rimini, M. L. D., Fiorelli, A., et al. (2026) · Thoracic Cancer · doi:10.1111/1759-7714.70259 · Cited by 1
Cancer Cytogenetics: Deep Roots, New Branches in the Age of Omics
Panagopoulos, I. (2026) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20580 · Cited by 1
Cho, M. S., Lee, S. I., Nam, H.-S., & Lee, Y.-J. (2026) · Life · doi:10.3390/life16050774 · Cited by 1
Sueyoshi, K., Kakiuchi, M., Komura, D., Katoh, H., Yamamoto, A., Kirimura, S., Onishi, I., Asakawa, A., Ishibashi, H., Ohashi, K., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117361 · Cited by 1
Myxoid Pleomorphic Liposarcoma: A Clinicopathological and Cytogenomic Study of 24 Cases
Ozcan, I., Zepeda‐Mendoza, C. J., Dermawan, J. K. T. K., Sukov, W. R., Larsen, B. T., & Folpe, A. L. (2026) · Modern Pathology · doi:10.1016/j.modpat.2026.101077 · Cited by 1
Llah, F. H. A. (2011) · UMK Repository (Universiti Malaysia Kelantan) · Cited by 1
Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response
Scaria, G. S., Kren, B. T., & Klein, M. A. (2020) · Pharmaceuticals · doi:10.3390/ph13020026 · Cited by 1
Mesothelioma Heterogeneity: Potential Mechanisms
Felley-Bosco, E. (2019) · MDPI eBooks · doi:10.3390/books978-3-03897-474-1 · Cited by 1
Genetic Alterations of Malignant Pleural Mesothelima
Wadowski, B. J., Severson, D. T., Bueno, R., & Rienzo, A. D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93756 · Cited by 1
Self-citationUpdate on mesothelioma diagnosis and classification
Zhang, Y. Z., Brambilla, C., & Nicholson, A. G. (2021) · Diagnostic histopathology · doi:10.1016/j.mpdhp.2021.05.001 · Cited by 1
Ojo de pez, observaciones de Michel Foucault
Alonso, J. S. (2010) · Debats: Revista de cultura, poder i societat · Cited by 1
Ahrendsen, J. T., Freund, R., Hsu, N. Y.-H., Bryke, C. R., & Varma, H. (2022) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlac091 · Cited by 1
The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition
Felley‐Bosco, E., Qi, W., Jean, D., Meiller, C., & Rehrauer, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032874 · Cited by 1
Diagnostic, prognostic, and therapeutic implications of genetic profiling in pleural mesothelioma
Sadek, A., Rienzo, A. D., & Bueno, R. (2023) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2023.17 · Cited by 1
Self-citationMa, K., Şendur, M. A. N., Cangır, A., Fırat, P., Göker, E., Kılıçkap, S., Uluç, B. O., Öz, B., Özdemir, F., & Özyiğit, G. (2023) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2023.101017 · Cited by 1
CHST4 Gene as a Potential Predictor of Clinical Outcome in Malignant Pleural Mesothelioma
Okado, S., Kato, T., Hanamatsu, Y., Emoto, R., Imamura, Y., Watanabe, H., Kawasumi, Y., Kadomatsu, Y., Ueno, H., Nakamura, S., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25042270 · Cited by 1
Testa, J. R., Kadariya, Y., & Friedberg, J. S. (2024) · Oncoscience · doi:10.18632/oncoscience.605 · Cited by 1
Malignant Mesothelioma: Overcoming Diagnostic Hurdles
Rajaram, P. D., Priyadarshini, S. G., & Jayaganesh, P. (2024) · Cureus · doi:10.7759/cureus.68718 · Cited by 1
Prognostic Stratification of Epithelioid Pleural Mesothelioma Based on the Hippo-TEADs Network
Poma, A. M., Bruno, R., Petrini, I., Stefano, I. D., Celi, A., Sbrana, A., Cappelli, S., Chella, A., Melfi, F. M. A., Lucchi, M., et al. (2025) · Cancers · doi:10.3390/cancers17030469 · Cited by 1
Pavlisko, E. N., Li, H., Piña‐Oviedo, S., Nel, A. E., Glass, C., & Sporn, T. A. (2025) · Springer eBooks · doi:10.1007/978-3-031-89250-9_5 · Cited by 1
Pasello, G., Remón, J., & Felley‐Bosco, E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.871544 · Cited by 1
Tung, Y.-G. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.26.684620 · Cited by 1
G�rard, M. (2023) · theses.fr (ABES) · doi:10.70675/13fa8eebz4aa6z47fdz88b1zaee99674ff4b · Cited by 1
In the literature: February 2019
Insa, A., Gambardella, V., & Cervantes, A. M. R. (2019) · ESMO Open · doi:10.1136/esmoopen-2019-000490
Ripley, R. T. (2020) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2020.03.056
Maintaining Equipoise With Maintenance Therapy in Mesothelioma
Mansfield, A. S. (2020) · Clinical Lung Cancer · doi:10.1016/j.cllc.2020.07.006
Personalizing treatment for malignant pleural mesothelioma
Quispel-Janssen, J. M. M. F. (2020) · Leiden Repository (Leiden University)
Inhibitors of cytoskeletal dynamics in malignant mesothelioma
Reis, K., Arbiser, J. L., Hjerpe, A., Dobra, K., & Aspenström, P. (2020) · Oncotarget · doi:10.18632/oncotarget.27843
Tumeurs rares : immunothérapies
Girard, N. (2020) · Revue des Maladies Respiratoires Actualités · doi:10.1016/s1877-1203(20)30153-1
Sekido, Y. (2021) · Respiratory disease series · doi:10.1007/978-981-15-9158-7_14
Self-citationFennell, D. A. (2021) · Respiratory disease series · doi:10.1007/978-981-15-9158-7_24
Emi, M., Gaudino, G., Yoshikawa, Y., & Ohmuraya, M. (2021) · Respiratory disease series · doi:10.1007/978-981-15-9158-7_12
Somatic data usage for classification of germ line variants
Walsh, M. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820519-8.00022-3
Effects of tumor mutation burden on the antigen presentation pathwayPreprint
Garcia-Rivera, E., Park, J., Desai, A. P., Boidot, R., Chevrier, S., Truntzer, C., Ghiringhelli, F., Borad, M. J., & Mansfield, A. S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.14.439829
Su, L., Wang, Y., Li, D., Wang, X., Liang, B., Ma, W., Guo, H., You, W., & Jiang, S. (2021) · Research Square · doi:10.21203/rs.3.rs-743274/v1
Pasello, G., Felley‐Bosco, E., & Remon, J. (2022) · Frontiers research topics · doi:10.3389/978-2-88974-818-1
Pass, H. I. (2019) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2019.10.127
Self-citationPeer Review #2 of "Machine learning analysis of TCGA cancer data (v0.1)"
(2021) · PeerJ Computer Science · doi:10.7287/peerj-cs.584v0.1/reviews/2
Peer Review #1 of "Machine learning analysis of TCGA cancer data (v0.1)"
(2021) · PeerJ Computer Science · doi:10.7287/peerj-cs.584v0.1/reviews/1
Maciá, S. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.89396
Peer Review #2 of "Machine learning analysis of TCGA cancer data (v0.2)"
(2021) · PeerJ Computer Science · doi:10.7287/peerj-cs.584v0.2/reviews/2
(2022) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477190-4
(2022) · American Registry of PathologyArlington, Virginia eBooks · doi:10.55418/9781933477190-3
Shao, M., Qiao, X. J., Chen, Q., Shi, H., & Yi, F. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14564
Yang, H., Gao, Y., Xu, D., Liang, S., Zhang, Y., Scherz, A., Hall, S. R. R., Forster, S., Berezowska, S., Yao, F., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4111073
Malignant Mesothelioma In Situ : A Controversial Diagnostic Entity – A Review
Kradin, R. L. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.106071
Voloaca, O. M. (2022) · Sheffield Hallam University · doi:10.7190/shu-thesis-00479
Strepkos, D., Markouli, M., Κλώνου, Α., Papavassiliou, A. G., & Piperi, C. (2023) · doi:10.1158/0008-5472.c.6512655.v1
Lee, H., Jang, H.-J., Ramineni, M., Wang, D. Y., Ramos, D., Choi, J. M., Splawn, T. G., Espinoza, M., Almarez, M., Hosey, L., et al. (2023) · doi:10.1158/1078-0432.22490402
Wirawan, A., Tajima, K., Takahashi, F., Mitsuishi, Y., Winardi, W., Hidayat, M., Hayakawa, D., Matsumoto, N., Izumi, K., Asao, T., et al. (2023) · doi:10.1158/1541-7786.c.6545018.v1
Self-citationB. Malignant Pleural Mesothelioma
Metintaş, M., Ak, G., & Røe, O. D. (2023) · Springer eBooks · doi:10.1007/978-3-031-22483-6_80-1
Molecular Pathology in a Mesothelioma Diagnosis
Nabeshima, K., Goto, Y., & Takizawa, K. (2023) · Haigan · doi:10.2482/haigan.63.835
Wang, C., Zhao, Y. F., & Liang, W. (2024) · Oncology Letters · doi:10.3892/ol.2024.14733
Santarpía, M., Aliprandi, M., Spagnolo, C. C., Avan, A., Rosell, R., Zucali, P. A., & Giovannetti, E. (2024) · Lung Cancer · doi:10.1016/j.lungcan.2024.108024
Duong, L., Jackaman, C., & Nelson, D. J. (2024) · Ageing and Cancer Research & Treatment · doi:10.70401/acrt.2025.0012
Chatelain, C. (2023) · theses.fr (ABES) · doi:10.70675/d0306d5az57a8z42c7zb131zd76c40a7af65
Mesothelioma and Immunotherapies
AlAhmadi, A., Roof, L., & Verschraegen, C. F. (2024) · touchREVIEWS in Oncology & Haematology · doi:10.17925/ohr.2024.20.2.4
Herman, E. J., Allione, A., Viberti, C., Manfredi, M., Russo, A., Hafeez, K. S., Kaiser, N., Johnen, G., Brüning, T., Mirabelli, D., et al. (2024) · SSRN Electronic Journal · doi:10.2139/ssrn.5060731
Hippo LATS Pathway in Cancer and Its Role as a Potential Target for Anti-cancer Drugs
Nabi, N., Taban, N., Muzaffar, M., Rashid, S. M., Khan, M. S., & Bhat, H. (2025) · Springer eBooks · doi:10.1007/978-981-96-2763-9_5
Kraft, A., Toenz, A., Schläpfer, F., Ronner, M., Orlowski, V., Kirschner, M. B., Felley-Bosco, E., Bein, J., Wild, P. J., Boeva, V., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.04.647264
Herman, E. J., Allione, A., Viberti, C., Manfredi, M., Russo, A., Hafeez, K. S., Kaiser, N., Johnen, G., Brüning, T., Mirabelli, D., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5213554
(2025) · Acta Scientific Medical Sciences · doi:10.31080/asms.2025.09.2068
Blyth, K. G., Tate, M., Meharry, R., & MacGregor, G. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-95311-5.00006-3
Jang, H.-J., Patel, M., Wang, D. Y., Kang, S. W., Choi, J. M., Lee, C., Vilchis, M., Shim, J. S., Mitra, S., Ranchod, P., et al. (2025) · doi:10.1158/1078-0432.29444600
van Genugten, J. H., Faulkner, D., Hahne, J. C., Poile, C., Wessels, L. F. A., Fennell, D. A., & Baas, P. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5360566
Baldavira, C. M., Qualiotto, A. N., Prieto, T. G., Fernezlian, S., Assato, A. K., Balancin, M. L., Takagaki, T. Y., Ab’Saber, A. M., Velosa, A. P. P., Teodoro, W. R., et al. (2025) · Glycoconjugate Journal · doi:10.1007/s10719-025-10192-z
Pervasive chromosomal instability drives the karyotypic evolution of hypodiploid tumours
Loughran, E., McLysaght, A., & Leathlobhair, M. N. (2026) · Genome Medicine · doi:10.1186/s13073-026-01632-y
Lee, H., Jang, H.-J., Ramineni, M., Wang, D. Y., Ramos, D., Choi, J. M., Splawn, T. G., Espinoza, M., Almarez, M., Hosey, L., et al. (2025) · doi:10.1158/1078-0432.30707257
Malignant mesothelioma in rare sites: two case reports
Du, Q., Guo, J., Zhu, Z., Zhang, Y., Cui, H., Xu, Z., Yang, R., & Liang, W. (2025) · Frontiers in Oncology · doi:10.3389/fonc.2025.1698949
Seyedshahi, F., Damiola, F., Lantuéjoul, S., Yuan, K., & Quesne, J. P. C. L. (2025) · arXiv (Cornell University) · doi:10.48550/arxiv.2512.01681
Offin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563847
Self-citationOffin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563841
Self-citationOffin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563844
Self-citationSingh, A., Pruett, N. D., Dixit, S., Gara, S. K., Wang, H., Pahwa, R., Schrump, D. S., & Hoang, C. D. (2023) · Figshare · doi:10.6084/m9.figshare.24580410
Sato, T., Nakanishi, H., Akao, K., Okuda, M., Mukai, S., Kiyono, T., & Sekido, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829953
Self-citationOffin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563829
Self-citationHo, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111140
Offin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563826
Self-citationOffin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563835
Self-citationHo, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111167
Offin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563823
Self-citationOffin, M. D., Sauter, J. L., Tischfield, S. E., Egger, J. V., Chavan, S. S., Shah, N., Manoj, P., Ventura, K., Allaj, V., de Stanchina, E., et al. (2022) · Figshare · doi:10.6084/m9.figshare.21563838
Self-citationHo, K.-H., Huang, T.-W., Shih, C.-M., Lee, Y.-T., Liu, A.-J., Chen, P.-H., & Chen, K.-C. (2021) · Figshare · doi:10.6084/m9.figshare.14111164
ROLES OF BAP1 IN CANCER AND LIVER DAMAGE RESPONSE
Sturgill, I. R. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/d8ks-ah71
Interrogating inter- and intratumour genomic heterogeneity in mesothelioma
Sharkey, A. J. (2020) · Figshare · doi:10.25392/leicester.data.12697562
Metadata
- Authors
- Hmeljak, J., Sanchez-Vega, F., Hoadley, K. A., Shih, J., Stewart, C., Heiman, D., Tarpey, P., Danilova, L., Drill, E., Gibb, E. A., Bowlby, R., Kanchi, R., Osmanbeyoglu, H. U., Sekido, Y., Takeshita, J., Newton, Y., Graim, K., Gupta, M., Gay, C. M., Diao, L., Gibbs, D. L., Thorsson, V., Iype, L., Kantheti, H., Severson, D. T., Ravegnini, G., Desmeules, P., Jungbluth, A. A., Travis, W. D., Dacic, S., Chirieac, L. R., Galateau-Sallé, F., Fujimoto, J., Husain, A. N., Silveira, H. C., Rusch, V. W., Rintoul, R. C., Pass, H., Kindler, H., Zauderer, M. G., Kwiatkowski, D. J., Bueno, R., Tsao, A. S., Creaney, J., Lichtenberg, T., Leraas, K., Bowen, J., TCGA Research Network, Felau, I., Zenklusen, J. C., Akbani, R., Cherniack, A. D., Byers, L. A., Noble, M. S., Fletcher, J. A., Robertson, A. G., Shen, R., Aburatani, H., Robinson, B. W., Campbell, P., Ladanyi, M., Aburatani, H., Akbani, R., Ally, A., Anur, P., Armenia, J., Auman, J. T., Balasundaram, M., Balu, S., Baylin, S. B., Becich, M., Behrens, C., Beroukhim, R., Bielski, C., Bodenheimer, T., Bootwalla, M. S., Bowen, J., Bowlby, R., Brooks, D., Bueno, R., Byers, L. A., Cárcano, F. M., Carlsen, R., Carvalho, A. L., Cherniack, A. D., Cheung, D., Chirieac, L., Cho, J., Chuah, E., Chudamani, S., Cibulskis, C., Cope, L., Crain, D., Creaney, J., Curley, E., Dacic, S., Danilova, L., Rienzo, A. D., DeFreitas, T., Demchok, J. A., Dhalla, N., Dhir, R., Diao, L., Drill, E., Felau, I., Feldman, M., Ferguson, M. L., Fletcher, J. A., Fujimoto, J., Fujimoto, J., Fukuda, S., Gabriel, S. B., Sallé, F. G., Gao, J., Gardner, J., Gastier-Foster, J. M., Gay, C. M., Gehlenborg, N., Gerken, M., Getz, G., Gibb, E. A., Gibbs, D. L., Goparaju, C., Graim, K., Gross, B., Guo, G., Gupta, M., Hasegawa, S., Haussler, D., Hayes, D. N., Heiman, D. I., Heins, Z., Hmeljak, J., Hoadley, K. A., Holt, R. A., Hoyle, A. P., Husain, A., Hutter, C. M., Iype, L., Jefferys, S. R., Jones, S. J. M., Jones, C. D., Kanchi, R. S., Kasaian, K., Kim, J., Kindler, H., Kondo, N., Krausz, T., Kundra, R., Kuribayashi, K., Kwiatkowski, D. J., Ladanyi, M., Lai, P. H., Laird, P. W., Lawrence, M. S., Lee, D., Leraas, K. M., Lichtenberg, T. M., Lin, P., Liu, J., Liu, W., Liu, E. M., Lolla, L., Longatto-Filho, A., Lu, Y., Luketich, J., Ma, Y., Maglinte, D. T., Mallory, D., Marra, M. A., Mayo, M., Meier, S., Melamed, J., Meng, S., Meyerson, M., Mieczkowski, P. A., Mills, G. B., Moore, R. A., Moran, C., Morris, S., Mose, L. E., Mungall, A. J., Mungall, K., Nakano, T., Naresh, R., Newton, Y., Noble, M. S., Ochoa, A., Osmanbeyoglu, H., Parker, J. S., Pass, H. I., Paulauskis, J., Pennathur, A., Pennell, N. A., Penny, R., Perou, C. M., Pihl, T., Ramirez, N. C., Rassl, D. M., Ravegnini, G., Reid, G., Reis, R. M., Reynolds, S. M., Rice, D., Richards, W. G., Rintoul, R. C., Roach, J., Robertson, A. G., Rusch, V., Sadeghi, S., Saksena, G., Sanchez-Vega, F., Sander, C., Sato, A., Scapulatempo-Neto, C., Schein, J. E., Schultz, N., Schumacher, S. E., Seiwert, T., Sekido, Y., Severson, D. T., Shelton, C., Shelton, T., Shen, R., Sheridan, R., Shi, Y., Shih, J., Shiraishi, Y., Shmulevich, I., Silveira, H. C. S., Simons, J. V., Sipahimalani, P., Skelly, T., Sofia, H. J., Soloway, M. G., Spellman, P., Stewart, C., Stuart, J., Sun, Q., Takeshita, J., Tam, A., Tan, D., Tarnuzzer, R., Tatsuno, K., Taylor, B. S., Thiessen, N., Thompson, E., Thorsson, V., Travis, W. D., Tsao, A., Tse, K., Tsujimura, T., Valdivieso, F., Van Den Berg, D. J., van Zandwijk, N., Veluvolu, U., Viana, L. S., Voet, D., Wan, Y., Wang, Z., Wang, J., Weaver, J., Weinstein, J. N., Weisenberger, D. J., Wilkerson, M. D., Wise, L., Wistuba, I., Wong, T., Wu, Y., Yamamoto, S., Yang, L., Zauderer, M. G., Zenklusen, J. C., Zhang, J., Zhang, H., Zhang, H., & Zmuda, E.
- Affiliations
- 3Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
- Wellcome Sanger Institute (GB)
- 10Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 11Computational Systems Biology, Memorial Sloan Kettering Cancer Center, New York, New York.
- The University of Texas at Dallas (US)
- Institut universitaire de cardiologie et de pneumologie de Québec (CA)
- Memorial Sloan Kettering Cancer Center (US)
- 23Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
- 24MESOPATH. Cancer Center Leon Berard, Lyon, France.
- 26Department of Pathology, University of Chicago, Chicago, Illinois.
- 27Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Sao Paulo, Brazil.
- 28Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
- 30Department of Cardiothoracic Surgery, NYU Langone Medical Center, New York, New York.
- 15Department of Thoracic Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
- 35The Research Institute at Nationwide Children's Hospital, Columbus, Ohio.
- 36National Cancer Institute, Bethesda, Maryland.
- 18Division of Thoracic Surgery, The Lung Center and International Mesothelioma Program, Brigham and Women's Hospital, Boston, Massachusetts.
- The University of Western Australia (AU)
- ORCID
- Tarpey, Patrick
- Kantheti, Havish
- Desmeules, Patrice
- Jungbluth, Achim A.
- Silveira, Henrique C.
- Tsao, Anne S.
- Robinson, Bruce W.
- Campbell, Peter
- Armenia, Joshua
- Auman, J. Todd
- Baylin, Stephen B.
- Becich, Michael
- Behrens, Carmen
- Beroukhim, Rameen
- Bootwalla, Moiz S.
- Cibulskis, Carrie
- Cope, Leslie
- Rienzo, Assunta De
- Dhir, Rajiv
- Ferguson, Martin L.
- Fukuda, Shiro
- Gabriel, Stacey B.
- Gao, Jianjiong
- Gehlenborg, Nils
- Getz, Gad
- Goparaju, Chandra
- Gross, Benjamin
- Guo, Guangwu
- Hasegawa, Seiki
- Haussler, David
- Hayes, D. Neil
- Heins, Zachary
- Holt, Robert A.
- Hoyle, Alan P.
- Jefferys, Stuart R.
- Jones, Steven J.M.
- Jones, Corbin D.
- Kasaian, Katayoon
- Kim, Jaegil
- Kondo, Nobuyuki
- Kundra, Ritika
- Kuribayashi, Kozo
- Laird, Peter W.
- Lawrence, Michael S.
- Lee, Darlene
- Lin, Pei
- Liu, Jia
- Liu, Wenbin
- Liu, Eric Minwei
- Lu, Yiling
- Luketich, James
- Maglinte, Dennis T.
- Marra, Marco A.
- Mayo, Michael
- Melamed, Jonathan
- Meyerson, Matthew
- Mieczkowski, Piotr A.
- Mills, Gordon B.
- Mungall, Andrew J.
- Nakano, Takashi
- Ochoa, Angelica
- Parker, Joel S.
- Pennathur, Arjun
- Pennell, Nathan A.
- Perou, Charles M.
- Pihl, Todd
- Ramirez, Nilsa C.
- Rassl, Doris M.
- Reid, Glen
- Reis, Rui M.
- Rice, David
- Richards, William G
- Roach, Jeffrey
- Sadeghi, Sara
- Saksena, Gordon
- Sander, Chris
- Sato, Ayuko
- Schultz, Nikolaus
- Schumacher, Steven E.
- Seiwert, Tanguy
- Shi, Yan
- Shiraishi, Yuichi
- Sofia, Heidi J.
- Spellman, Paul
- Sun, Qiang
- Tam, Angela
- Tarnuzzer, Roy
- Tatsuno, Kenji
- Taylor, Barry S
- Tsujimura, Tohru
- Wang, Jing
- Weaver, Joellen
- Weinstein, John N.
- Weisenberger, Daniel J.
- Wilkerson, Matthew D.
- Wistuba, Ignacio
- Wong, Tina
- Wu, Ye
- Yamamoto, Shogo
- Yang, Liming
- Zhang, Jiashan
- Zhang, Hailei
- Zhang, Hongxin
- Zmuda, Erik
- Venue
- Cancer Discovery
- Published
- 2018-12-01
- Volume
- 8
- Issue
- 12
- Pages
- 1548-1565
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC6310008
- OpenAlex
- W2897299514
- Cited by
- 618
- References
- 62
- Citations by year
- 2026: 53 · 2025: 62 · 2024: 61 · 2023: 78 · 2022: 96 · 2021: 117 · 2020: 100 · 2019: 45 · 2018: 4
- FWCI
- 50.06
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Cancer Discovery (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
- Funders
- HHS | National Institutes of Health (NIH) (U54 HG003273, U24 CA143858, U24 CA143866, U24 CA143867, U24 CA143882, U24 CA143883, U24 CA144025, P30 CA016672, P30 CA008748, U54 HG003067, U54 HG003079, U24 CA143799, U24 CA143835, U24 CA143840, U24 CA143843, U24 CA143845, U24 CA143848)
- British Lung Foundation (BLF) (APG11-7)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- malignant pleural mesothelioma, TP53 mutation, loss of heterozygosity, genomic subtypes, VISTA, immune checkpoint, epithelioid mesothelioma, immunotherapy, antitumor immunity
- MeSH terms
- Aged, Female, Humans, Lung Neoplasms, Male, Mesothelioma, Middle Aged, Mutation, Pleural Neoplasms, Prognosis, Histone-Lysine N-Methyltransferase, Protein Methyltransferases, Biomarkers, Tumor, Tumor Suppressor Proteins, Ubiquitin Thiolesterase, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.